Drug Intermediate
Drug Iintermediate
Drug intermediates are used as raw materials for the production of bulk drugs, or they can refer to a material produced during synthesis of an API that must undergo further molecular change or processing before it becomes an API. Drug intermediates are hygienically formulated using high grade raw materials and they are used in the pharmaceutical and cosmetic industry[1][2].
Références:
- [1]. Ma HC, et al. Homochiral Covalent Organic Framework for Catalytic Asymmetric Synthesis of a Drug Intermediate. J Am Chem Soc. 2020 Jul 22;142(29):12574-12578. [Content Brief]
- [2]. Ramachary D B, et al. Development of pharmaceutical drugs, drug intermediates and ingredients by using direct organo‐click reactions[J]. 2008.
All Product Categories
-
Drug Intermediate Produits associés (4742)
Produits associés (4742)
-
Buspirone impurity 5
0 ImagesCat. No.: HY-W208792CAS No.: 81461-73-6Synonyms: Buspirone impurity BBuspirone impurity 5 (Buspirone impurity B) is an impurity of Buspirone.
-
p-SCN-Bn-DOTA(tBu)4
0 ImagesCat. No.: HY-164981CAS No.: 1703752-99-1p-SCN-Bn-DOTA(tBu)4 is the derivative of DOTA (HY-W053583). p-SCN-Bn-DOTA(tBu)4 is the component of the Gd(III)-DOTA-IAC, which is a targeted magnetic resonance imaging (MRI) contrast agent for αvβ3 integrin receptor.
-
Metoprolol impurity 6
0 ImagesCat. No.: HY-W700713CAS No.: 29112-40-1Metoprolol impurity 6 is an impurity of Metoprolol.
-
Olmesartan impurity 3
0 ImagesCat. No.: HY-W416485CAS No.: 172875-59-1Olmesartan impurity 3 is an impurity of Olmesartan.
-
Leflunomide impurity 3
0 ImagesCat. No.: HY-W011669CAS No.: 61643-23-0Synonyms: Leflunomide 3-IsomerLeflunomide impurity 3 (Leflunomide 3-Isomer) is an impurity of Leflunomide.
-
Ethyl-2,4-dimethyl-thiazole-5-carboxylate
0 ImagesEthyl-2,4-dimethyl-thiazole-5-carboxylate is a building block in the chemical synthesis.
-
1,1,1,3-Tetrachloroacetone
0 ImagesCat. No.: HY-133629CAS No.: 16995-35-01,1,1,3-Tetrachloroacetone is a halogenated ozone-chlorine and ozone chloramine disinfection byproducts (DBPs) at elevated bromide levels when chlorine or chloramine is used as a secondary disinfectant.
-
Sofosbuvir impurity 6
0 ImagesCat. No.: HY-I0699CAS No.: 1496551-71-3
-
Dacomitinib impurity 16
0 ImagesCat. No.: HY-Z6413CAS No.: 2803456-91-7
-
Duloxetine impurity 8
0 ImagesCat. No.: HY-Z19664CAS No.: 116817-27-7Duloxetine impurity 8 is an impurity of Duloxetine.
-
Mdl 28815
0 ImagesCat. No.: HY-187586CAS No.: 104905-12-6Mdl 28815 is an inhibitor of Sterol-delta 14-reductase and 2,3-oxido-squalene cyclase, with IC50 values of 0.07 μM and 2 μM, respectively. Mdl 28815 blocks cholesterol biosynthesis and causes the accumulation of specific sterol metabolites. Mdl 28815 is applicable to research related to hypercholesterolemia.
-
Rosuvastatin impurity 33
0 ImagesCat. No.: HY-Z16545CAS No.: 615556-96-2Rosuvastatin impurity 33 is an impurity of Rosuvastatin.
-
Candesartan impurity 3
0 ImagesCat. No.: HY-W701180CAS No.: 1798004-41-7Candesartan impurity 3 is an impurity of Candesartan.
-
N‐Nitrosociprofloxacin
0 ImagesCat. No.: HY-W753945CAS No.: 864443-44-7N‐Nitrosociprofloxacin is a Ciprofloxacin (HY-B0356) impurity.
-
Atenolol impurity 8
0 ImagesCat. No.: HY-Z7633CAS No.: 115538-83-5Atenolol impurity 8 is an impurity of Atenolol.
-
Clozapine impurity 3
0 ImagesCat. No.: HY-Z8494CAS No.: 65514-71-8Clozapine impurity 3 is an impurity of Clozapine.
